>>> Baxter beats by $0.05, reports revs in-line; guides Q1 EPS below consensus,

Baxter beats by $0.05, reports revs in-line; guides Q1 EPS below consensus, revs in-line; guides FY18 EPS above consensus, revs above consensus (72.03)

Reports Q4 (Dec) earnings of $0.64 per share, excluding non-recurring items, $0.05 better than the Capital IQ Consensus of $0.59; revenues rose 4.9% year/year to $2.77 bln vs the $2.77 bln Capital IQ Consensus.
Co issues guidance for Q1, sees EPS of $0.60-0.62, excluding non-recurring items, vs. $0.63 Capital IQ Consensus Estimate; sees Q1 revs of +5-6% (Approx $2.598-2.623 bln) vs. $2.61 bln Capital IQ Consensus Estimate.
Co issues upside guidance for FY18, sees EPS of $2.72-2.80, excluding non-recurring items, vs. $2.72 Capital IQ Consensus Estimate; sees FY18 revs of +6-7% (Approx $11.2-11.3 bln) vs. $11.1 bln Capital IQ Consensus Estimate.